Skip to main content

Pulse Biosciences, Inc.

PLSE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001625101

In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Pulse Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of PLSE: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders55148−6
Shares4.11M26.4K4.07M−13.3K (−0.3%)
Value$88.9M$571.0K$60.3M−$27.9M (−31.7%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Pulse Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to PLSE in Q4 2021
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP11,102$164.0K0.02%
UBS Group AG6,794$101.0K0.00%
CWM, LLC1,050$16.0K0.00%

Sold out (9)

Institutions that held Pulse Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of PLSE in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
M&G Investment Management Ltd65,132$1.43M
Two Sigma Investments, LP21,074$455.0K
Vontobel Holding Ltd.20,000$432.0K
MetLife Investment Management5,276$114.0K
SG Americas Securities, LLC4,717$102.0K
Metropolitan Life Insurance Co3,991$86.2K
Simplex Trading, LLC505$10.0K
Horizon Financial Services, LLC400$9.00K
Parallel Advisors, LLC250$5.00K

Not filed for Q4 2021 yet (1)

Institutions that held Pulse Biosciences, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PLSE in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Spotlight Asset Group, Inc.26,425$571.0K